Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback